A director at Sacyr S.A. sold 205,000 shares at 3.370EUR and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CELLNEX, ENAGÁS, MELIÁ. EUROPA: SECTOR AUTO, SIEMENS. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’24 que se publicarán en España y Europa en los próximos días. El Ibex a un paso de los 13.400 puntos Las bolsas de Europa volvieron a acercarse a los máximos del año, a pesar de los numerosos frentes que ...
NEWS SUMMARY: CELLNEX, ENAGÁS, MELIÁ. The Ibex near 13,400 points European stock markets traded near the highs hit in the last few days amid many concerns (tariffs to Canada and Mexico will come into force next Tuesday and the situation in Ukraine is uncertain given the commitment of the Trump administration). Thus, in the STOXX 600, Industrials (fuelled by defence companies) and Basic Resources were the best performers vs. Real Estate and Utilities that were the only sectors ending in negativ...
4Q'24 vs. 4Q'23 Results Sales: € 1.309 Bn (-4.1% vs. -15.5% BS(e) and -15.6% consensus); EBITDA: € 404.2 M (-25.6% vs. -34.8% BS(e) and -31.6% consensus); EBIT: € 355.0 M (-12.2% vs. -22.8% BS(e) and -14.7% consensus); Net Profit: € 39.0 M (-36.1% vs. -36.4% BS(e) and -18.0% consensus); FY2024 vs. FY2023 Results Sales: € 4.571 Bn (-0.8% vs. -4.2% BS(e) and -4.2% consensus); EBITDA: € 1.352 Bn (-11.2% vs. -14.5% BS(e) and -13.4% consensus); EBIT: € 1.225 Bn (-2.0% vs. -5.5% BS(e) and -2.8% consen...
Rdos. 4T'24 vs 4T'23: Ventas: 1.309 M euros (-4,1% vs -15,5% BS(e) y -15,6% consenso); EBITDA: 404,2 M euros (-25,6% vs -34,8% BS(e) y -31,6% consenso); EBIT: 355,0 M euros (-12,2% vs -22,8% BS(e) y -14,7% consenso); BDI: 39,0 M euros (-36,1% vs -36,4% BS(e) y -18,0% consenso). Rdos. 2024 vs 2023: Ventas: 4.571 M euros (-0,8% vs -4,2% BS(e) y -4,2% consenso); EBITDA: 1.352 M euros (-11,2% vs -14,5% BS(e) y -13,4% consenso); EBIT: 1.225 M euros (-2,0% vs -5,5% BS(e) y -2,8% consenso); BDI: 113,0 ...
NEWS SUMMARY: ACERINOX, ACCIONA, ACCIONA ENERGÍA, ACS, AMADEUS, COLONIAL, ENCE, FERROVIAL, GRIFOLS, MELIÁ HOTELES, MERLIN PROPERTIES, PUIG BRANDS, REPSOL, SACYR, VISCOFAN. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 4Q’24 results to be released over the coming days in Spain. Losses in Europe Despite many companies releasing their 4Q’24 results yesterday, the session was mar...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACERINOX, ACCIONA, ACCIONA ENERGÍA, ACS, AMADEUS, COLONIAL, ENCE, FERROVIAL, GRIFOLS, MELIÁ HOTELES, MERLIN PROPERTIES, PUIG BRANDS, REPSOL, SACYR, VIDRALA, VISCOFAN. EUROPA: ALLIANZ, BASF, ENI. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’24 que se publicarán en España y Europa en los próximos días. P...
4Q'24 vs. 4Q'23 Results Sales: € 1.431 Bn (+5.0% vs. +2.9% BS(e) and +5.8% consensus); EBITDA: € 847.1 M (-6.8% vs. -8.3% BS(e) and -7.7% consensus); Net Profit: € 484.4 M (-2.1% vs. +6.5% BS(e) and -9.5% consensus); FY2024 vs. FY2023 Results Sales: € 5.828 Bn (+13.3% vs. +12.8% BS(e) and +13.6% consensus); EBITDA: € 3.51 Bn (+16.1% vs. +15.7% BS(e) and +15.9% consensus); Net Profit: € 1.934 Bn (+17.6% vs. +20.2% BS(e) and +15.4% consensus);
Rdos. 4T'24 vs 4T'23: Ventas: 1.431 M euros (+5,0% vs +2,9% BS(e) y +5,8% consenso); EBITDA: 847,1 M euros (-6,8% vs -8,3% BS(e) y -7,7% consenso); BDI: 484,4 M euros (-2,1% vs +6,5% BS(e) y -9,5% consenso). Rdos. 2024 vs 2023: Ventas: 5.828 M euros (+13,3% vs +12,8% BS(e) y +13,6% consenso); EBITDA: 3.510 M euros (+16,1% vs +15,7% BS(e) y +15,9% consenso); BDI: 1.934 M euros (+17,6% vs +20,2% BS(e) y +15,4% consenso).
NEWS SUMMARY: AENA, CELLNEX, EBRO FOODS, GLOBAL DOMINION, REDEIA. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 4Q’24 results to be released over the coming days in Spain. IBEX continues bullish streak It was another session that ended worse than it began for European stock markets, dragged down by the poor opening in the US in view of the doubts being generated by the deteri...
A director at Enagas SA bought 12,396 shares at 12.110EUR and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.